BackgroundThe present paper provides an updated review of both the large number of
new/novel/emerging psychoactive substances (NPS) and their associated …

Pharmaceutical poisoning is a significant global public health concern, causing
approximately 190,000 deaths annually. This scoping review aims to comprehensively map …

Fatal opioid poisonings often involve methadone or morphine. This study aimed to elucidate
if quetiapine, a widely used sedative antipsychotic medication, may increase the risk of fatal …

Background: Second-generation antipsychotics (SGAs) are assumed to have little abuse
potential. However, reports of quetiapine abuse have emerged as prescribing has increased …

Quetiapine is an antipsychotic medication indicated for schizophrenia and bipolar disorder.
However, quetiapine also has hypnotic properties and as such is increasingly being …

Background: Quetiapine, an atypical antipsychotic endowed with weak dopamine
antagonist, potent 5-HT2A-blocking, partial 5-HT1A-agonist, anti-H1 histamine, adrenolytic …

Aims There are increasing concerns about harms related to suboptimal antipsychotic use.
Here we describe recent population‐based trends in antipsychotic use and harms in …

Australia spends more than $20 billion annually on medicines, delivering significant health
benefits for the population. However, inappropriate prescribing and medicine use also result …

Objective Borderline personality disorder (BPD) is common and poses many clinical
challenges. Despite limited evidence of effectiveness, psychotropic medications are often …

Psychotropic prescription drugs are commonly involved in intoxication events. The study's
aim was to determine a comparative risk for intoxication in relation to prescribing rates for …